Camp4 Therapeutics Corp (CAMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 1,779 | 1,294 | 348 | 795 | 1,497 |
| Gross Profit | 1,779 | 1,294 | 348 | 795 | 1,497 |
| Operating Expenses | 15,159 | 14,365 | 13,124 | 14,446 | 14,525 |
| Operating Income | -13,380 | -13,071 | -12,776 | -13,651 | -13,028 |
| Other Income | -20,150 | -5,260 | -27,508 | -1,448 | 441 |
| Pre-tax Income | -33,530 | -18,331 | -40,284 | -15,099 | -12,587 |
| Net Income Continuous | -33,530 | -18,331 | -40,284 | -15,099 | -12,587 |
| Net Income | $-33,530 | $-18,331 | $-40,284 | $-15,099 | $-12,587 |
| EPS Basic Total Ops | -0.58 | -0.32 | -0.86 | -0.55 | -0.62 |
| EPS Basic Continuous Ops | -0.58 | -0.32 | -0.85 | -0.55 | -0.62 |
| EPS Diluted Total Ops | -0.58 | -0.32 | -0.86 | -0.55 | -0.62 |
| EPS Diluted Continuous Ops | -0.58 | -0.32 | -0.85 | -0.55 | -0.62 |
| EPS Diluted Before Non-Recurring Items | -0.22 | -0.32 | -0.87 | -0.55 | -0.62 |
| EBITDA(a) | $-12,865 | $-12,551 | $-12,404 | $-13,235 | $-12,598 |